ALPS Medical Breakthroughs ETF Rating → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free SBIO Stock Alerts $33.66 +0.04 (+0.12%) (As of 05/31/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy2.82Holdings in SBIO have an aggregate rating of Moderate Buy based on 401 analyst ratings issued in the past year covering 50 companies (84.1% of the portfolio).SBIO Aggregate Price Target$53.6259.30% UpsideHigh Prediction$74.85Average Prediction$53.62Low Prediction$36.43Holdings in SBIO have an aggregate price target of $53.62 and a range of $36.43 to $74.85 covering 50 companies (84.1% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy22 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 SBIO Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.16%VKTXViking Therapeutics$62.26+0.8%4 of 5 stars3.11$112.38 80.5%9Analyst Upgrade4.88%PCVXVaxcyte$70.27+0.1%1 of 5 stars3.00$78.50 11.7%4Insider SellingPositive News4.84%CERECerevel Therapeutics$40.74+0.2%0 of 5 stars2.11$42.67 4.7%9Short Interest ↑News Coverage4.09%RVMDRevolution Medicines$38.33+0.4%4 of 5 stars3.10$43.20 12.7%10Positive News2.69%ALPNAlpine Immune Sciences$64.97+0.0%2 of 5 stars2.27$52.33 -19.5%11Positive NewsHigh Trading Volume2.54%ALKSAlkermes$23.40+0.8%5 of 5 stars2.50$36.78 57.2%10High Trading Volume2.48%CRNXCrinetics Pharmaceuticals$44.41-2.1%4 of 5 stars2.92$60.92 37.2%12Insider Selling2.27%AXSMAxsome Therapeutics$73.43-1.1%5 of 5 stars2.92$121.92 66.0%13Insider Selling2.10%SWTXSpringWorks Therapeutics$41.46-2.7%1 of 5 stars3.00$68.83 66.0%6Analyst Forecast1.99%SMMTSummit Therapeutics$8.69-20.4%1 of 5 stars3.00$10.50 20.9%2Analyst ForecastOptions VolumeNews CoverageGap DownHigh Trading Volume1.97%IDYAIDEAYA Biosciences$36.55+2.1%3 of 5 stars3.00$46.80 28.0%12Insider SellingNews Coverage1.92%XENEXenon Pharmaceuticals$38.07-2.5%2 of 5 stars3.00$59.11 55.3%9Options VolumeHigh Trading Volume1.83%DNLIDenali Therapeutics$18.56+0.5%4 of 5 stars2.89$40.22 116.7%9Short Interest ↓Positive News1.82%CORTCorcept Therapeutics$30.17-3.3%5 of 5 stars3.00$40.10 32.9%4Analyst ForecastInsider SellingAnalyst RevisionNews Coverage1.76%IMCRImmunocore$48.98+4.9%2 of 5 stars2.87$81.85 67.1%15Analyst ForecastNews Coverage1.72%ACLXArcellx$52.00-0.5%3 of 5 stars3.07$78.00 50.0%14Analyst ForecastPositive NewsGap Up1.65%MRUSMerus$53.24-7.1%2 of 5 stars3.00$63.80 19.8%12Analyst ForecastAnalyst Revision1.63%CLDXCelldex Therapeutics$33.30-1.0%2 of 5 stars2.80$66.00 98.2%5Short Interest ↓Positive News1.59%NTLAIntellia Therapeutics$21.38-3.3%4 of 5 stars2.69$66.77 212.3%13Analyst RevisionPositive News1.57%ACADACADIA Pharmaceuticals$15.10+0.7%4 of 5 stars2.75$28.94 91.6%16Analyst Revision1.54%MLTXMoonLake Immunotherapeutics$40.66-0.9%1 of 5 stars2.75$74.46 83.1%12Positive News1.50%VCELVericel$47.70-1.0%0 of 5 stars3.00$46.80 -1.9%6Positive News1.50%RYTMRhythm Pharmaceuticals$35.68-2.7%3 of 5 stars2.83$54.33 52.3%61.48%VERAVera Therapeutics$37.99+2.8%1 of 5 stars3.00$42.86 12.8%8Analyst Forecast1.48%RNAAvidity Biosciences$26.86-0.7%2 of 5 stars3.00$41.33 53.9%6Positive NewsGap Down1.39%ARVNArvinas$33.14+2.8%3 of 5 stars2.88$61.13 84.5%16Positive News1.34%GERNGeron$3.55+2.3%4 of 5 stars2.80$6.10 71.8%5Positive News1.30%ZLABZai Lab$17.78-2.3%3 of 5 stars3.00$64.22 261.2%5Short Interest ↓Positive NewsHigh Trading Volume1.30%DCPHDeciphera Pharmaceuticals$25.54+0.0%3 of 5 stars2.30$24.17 -5.4%10Short Interest ↓Positive News1.25%AGIOAgios Pharmaceuticals$36.34-3.2%2 of 5 stars2.50$35.00 -3.7%4Analyst UpgradeShort Interest ↓Analyst Revision1.24%CPRXCatalyst Pharmaceuticals$16.17+0.4%5 of 5 stars3.00$26.71 65.2%5Positive News1.23%KROSKeros Therapeutics$46.87+1.2%2 of 5 stars3.00$86.00 83.5%7News CoveragePositive News1.21%GLPGGalapagos$27.82+1.3%0 of 5 stars1.67$34.50 24.0%3News Coverage1.18%SNDXSyndax Pharmaceuticals$19.27-0.1%4 of 5 stars2.91$34.42 78.6%11Positive News1.16%PTGXProtagonist Therapeutics$28.15+1.6%3 of 5 stars3.00$38.00 35.0%4Gap Down1.05%KURAKura Oncology$20.61-0.4%3 of 5 stars2.86$27.94 35.6%7Positive News1.04%EWTXEdgewise Therapeutics$17.13-2.1%2 of 5 stars3.00$31.20 82.1%5Positive News1.03%INBXInhibrx$16.25+2.5%5 of 5 stars2.00$27.00 66.2%2Upcoming EarningsInsider SellingShort Interest ↓News Coverage1.00%RCUSArcus Biosciences$15.07+0.9%2 of 5 stars2.88$41.25 173.7%8News Coverage0.95%MORFMorphic$30.37-1.5%4 of 5 stars2.67$51.50 69.6%60.93%NMRANeumora Therapeutics$9.90+2.2%1 of 5 stars2.86$22.57 128.0%7Positive NewsGap Up0.91%TARSTarsus Pharmaceuticals$32.96-5.1%2 of 5 stars2.88$50.38 52.8%8Positive News0.90%DAWNDay One Biopharmaceuticals$13.27-2.4%3 of 5 stars2.86$37.67 183.8%7Short Interest ↓Analyst Revision0.87%SLNOSoleno Therapeutics$42.08-1.3%4 of 5 stars3.14$60.33 43.4%7Positive News0.85%VIRVir Biotechnology$10.27-1.2%2 of 5 stars2.57$33.57 226.9%7Gap Down0.83%BCRXBioCryst Pharmaceuticals$6.46-1.7%4 of 5 stars3.00$14.00 116.7%7Positive News0.82%XNCRXencor$23.76-0.5%4 of 5 stars2.86$35.43 49.1%7Positive News0.80%FDMT4D Molecular Therapeutics$23.97-2.7%2 of 5 stars3.00$44.22 84.5%10Positive News0.76%PRTAProthena$20.81+3.0%2 of 5 stars2.71$67.00 222.0%7Analyst Revision0.76%MNKDMannKind$4.67+3.8%3 of 5 stars3.00$8.00 71.3%3 This page (NYSEARCA:SBIO) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsLEAKED: Jeff Bezos' $330 Million GambleBehind the MarketsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
